BSECompany Update3d ago · 10 Aug 2026, 09:34 pm

Disclosure under Regulation 30 of SEBI Listing Regulations

Aarti Drugs Ltd · 524348

✦ AI Summary▲ PositiveLitigation

Aarti Drugs Ltd has informed that the Hon'ble Supreme Court of India has dismissed the Special Leave Petition filed by the GST Department, disposing of the matter in favor of the company.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aarti Drugs Ltd - 524348 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")

Attachments (1)

📄

d2082444-12ae-4e80-bbda-a7085bccf96f.pdf

pdf

Download →
View document text
Ref: ADL/SE/2026-27/37 August 10, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai – 400051 BSE CODE: 524348 NSE SYMBOL: AARTIDRUGS Dear Sir/Madam, Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") This is with reference to our earlier intimation dated March 16, 2026, bearing reference number ADL/SE/2025-26/77, regarding the order passed by the Hon’ble High Court of Judicature at Bombay, which was challenged by the GST Department by filing a Special Leave Petition before the Hon’ble Supreme Court of India. We wish to inform you that the Hon’ble Supreme Court of India has dismissed the Special Leave Petition filed by the GST Department. Accordingly, the matter stands disposed of by the Hon’ble Supreme Court. The details as required under Para B of Part A of Schedule III under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 are as under: - Sr. Details of Events need to be Information of such Event No. provided 1. name(s) of the opposing party GST Department 2. Litigation against Company court/ tribunal/agency where 3. Hon’ble Supreme Court of India litigation is filed The Company had received Show Cause Notice for alleged contravention of Rule 96(10) of CGST Rule proposing to demand IGST of Rs. 230.70 Crores along with applicable interest and penalty for FY 2017-18 to FY 2021-22. In continuation to the aforesaid Show Cause Notice, CGST & C.Ex. Authority passed the Order which, inter alia, included:- - Demand of erroneous sanctioned IGST refund of Rs. 20.72 Crores under Section 74(9) of the CGST Act, 2017 - Drop the demand of Rs. 209.98 Crores under Section 74 of the CGST Act, 2017 read with Section 20 of IGST Act 2017 - Demand of interest at the rates prescribed under the provisions of Section 50(1) of the CGST Act, 2017 - Imposition of penalty of Rs. 20.72 Crores under Section 74(9) of CGST Act, 2017 read Litigation/ dispute for which this with Section 122(2)(b) of CGST Act, 2017 4. disclosure is being made (brief details of dispute/litigation) The Company had filed writ petition at The High Court of Judicature at Bombay against the demand/ penalty mentioned in the aforesaid order of CGST & C.Ex. Authority. The Hon’ble High Court subsequently passed an order setting aside the said order of the CGST & C.Ex. Authority. Then, the GST department challenged the aforesaid Order of the Hon’ble High Court by filing a Special Leave Petition before the Hon’ble Supreme Court of India. Now, the Hon’ble Supreme has dismissed the Special Leave Petition filed by GST Department. Accordingly, the matter stands disposed of by the Hon’ble Supreme Court. Date on which original 5. March 16, 2026 disclosure was made Details of the development in relation to the existing The Hon’ble Supreme has dismissed the Special 6. proceeding/ Details of Change Leave Petition filed by GST Department. in Status There is no impact on the financial, operation or expected financial implications, other activities of the Company as the order passed 7. if any, due to compensation, by Hon’ble Supreme Court is in favour of the penalty etc. Company. This is for your information and records. Thanking you, Yours faithfully, FOR AARTI DRUGS LIMITED RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M. No.: F12932